Akkaif, Mohammed Ahmed and Bitar, Ahmad Naoras and Al-Kaif, Laith A. I. K. and Daud, Nur Aizati Athirah and Sha'aban, Abubakar and Noor, Dzul Azri Mohamed and Abd Aziz, Fatimatuzzahra' and Cesaro, Arturo and Kader, Muhamad Ali Sk Abdul and Wahab, Mohamed Jahangir Abdul and Khaw, Chee Sin and Ibrahim, Baharudin (2022) The management of myocardial injury related to SARS-CoV-2 pneumonia. Journal of Cardiovascular Development and Disease, 9 (9). ISSN 2308-3425, DOI https://doi.org/10.3390/jcdd9090307.
Full text not available from this repository.Abstract
The global evolution of the SARS-CoV-2 virus is known to all. The diagnosis of SARS-CoV-2 pneumonia is expected to worsen, and mortality will be higher when combined with myocardial injury (MI). The combination of novel coronavirus infections in patients with MI can cause confusion in diagnosis and assessment, with each condition exacerbating the other, and increasing the complexity and difficulty of treatment. It would be a formidable challenge for clinical practice to deal with this situation. Therefore, this review aims to gather literature on the progress in managing MI related to SARS-CoV-2 pneumonia. This article reviews the definition, pathogenesis, clinical evaluation, management, and treatment plan for MI related to SARS-CoV-2 pneumonia based on the most recent literature, diagnosis, and treatment trial reports. Many studies have shown that early diagnosis and implementation of targeted treatment measures according to the different stages of disease can reduce the mortality rate among patients with MI related to SARS-CoV-2 pneumonia. The reviewed studies show that multiple strategies have been adopted for the management of MI related to COVID-19. Clinicians should closely monitor SARS-CoV-2 pneumonia patients with MI, as their condition can rapidly deteriorate and progress to heart failure, acute myocardial infarction, and/or cardiogenic shock. In addition, appropriate measures need to be implemented in the diagnosis and treatment to provide reasonable care to the patient.
| Item Type: | Article |
|---|---|
| Funders: | UNSPECIFIED |
| Uncontrolled Keywords: | Myocardial injury; SARS-CoV-2; Management; Pathogenesis |
| Subjects: | R Medicine |
| Divisions: | Faculty of Pharmacy |
| Depositing User: | Ms. Juhaida Abd Rahim |
| Date Deposited: | 07 Sep 2023 04:06 |
| Last Modified: | 07 Sep 2023 04:06 |
| URI: | http://eprints.um.edu.my/id/eprint/41125 |
Actions (login required)
 |
View Item |
